CAH vs HYPR · P/E 35, rev $254.25B vs rev $7.8M
Cardinal Health Inc (CAH) versus Hyperfine Inc (HYPR) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Hyperfine Inc (HYPR) is a medical devices company listed on NASDAQ.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported HYPR revenue for 2026-06-30 was $7.8M. Net income was -$17.9M. HYPR currently screens at market cap $141.5M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. HYPR currently screens at market cap $141.5M.
Not investment advice. Open the CAH and HYPR stock pages for the full models.
Not investment advice.